Bellevue Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bellevue Group’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-23,517	Closed	-$1.08M	–	225
2019 Q3	$1.08M	Sell	23,517 -23,400	-50%	-$1.32M	0.02%	142
2019 Q2	$2.75M	Hold	46,917	–	–	0.05%	122
2019 Q1	$2.1M	Buy	46,917 +16,600	+55%	+$761K	0.12%	105
2018 Q4	$1.18M	Sell	30,317 -500	-2%	-$19.6K	0.08%	112
2018 Q3	$1.42M	Sell	30,817 -600	-2%	-$24.3K	0.09%	115
2018 Q2	$1.37M	Buy	+31,417	New	+$1.35M	0.12%	107

Other funds holding ARNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bellevue Group's ARNA Position: Q4 2019 in Review

Bellevue Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2019, closing a stake of 23,517 shares — an estimated $1.08M sold.

Bellevue Group first reported a position in ARNA in Q2 2018 and held it in 6 quarters. The position peaked at $2.75M in Q2 2019. 226 funds tracked by Wall St. Rank hold ARNA as of Q4 2019.

Bellevue Group reported no remaining Arena Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
Bellevue Group sold 23,517 Arena Pharmaceuticals Inc shares in Q4 2019, an estimated $1.08M.
Bellevue Group first reported a position in Arena Pharmaceuticals Inc in Q2 2018 and held it in 6 quarters.
Bellevue Group's Arena Pharmaceuticals Inc position peaked at $2.75M in Q2 2019.
226 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2019.

Based on Bellevue Group's 13F filing for Q4 2019, filed 14 Feb 2020.